The ITT analyses resulted in rates of 85 % ( 95 % CI , 66.5-96 .9 ) for the 10-d reinforced therapy with DeNol and was 80 % ( 95 % CI : 60.2-94 .1 ) for the 10-d reinforced therapy with Novobismol ( P = 0.68 ) , while the PP analyses resulted in 100 % ( 95 % CI , 94.5-100 .0 ) and 94.1 % ( 95 % CI : 78.3-99 .9 ) , respectively ( P = 0.31 ) .